vimarsana.com

Latest Breaking News On - Pfizer news - Page 6 : vimarsana.com

Pfizer Inc : TIVDAK Supplemental Biologics License Application Accepted for Priority Review by FDA for Patients with Recurrent or Metastatic Cervical Cancer

Pfizer Inc : TIVDAK Supplemental Biologics License Application Accepted for Priority Review by FDA for Patients with Recurrent or Metastatic Cervical Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Pfizer gene therapy for bleeding disorder approved in Canada

Canada: Pfizer said on Wednesday that Canada s health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B ahead of a U.S. decision.The.

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts

Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pfizer Completes Acquisition of Seagen

Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Seagen Inc. (NASDAQ: SGEN), a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.